MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$6,458K
EPS
-$0.69
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
4,002
4,911
8,283
3,603
General and administrative
2,627
2,140
-1,297
2,335
Total operating expenses
6,629
7,051
6,986
5,938
Loss from operations
-6,629
-7,051
-9,555
-5,938
Interest income
172
247
193*
411
Other income (expense), net
-
-
-2,586*
-
Net (loss) income
-6,457
-6,804
-11,948
-5,527
Unrealized loss on short-term investments
-1
-7
3
20
Comprehensive (loss) income
-6,458
-6,811
-11,945
-5,507
Basic EPS
-0.69
-0.73
-1.61
-0.59
Diluted EPS
-0.69
-0.73
-1.535
-0.59
Basic Average Shares
9,381,344
9,381,344
7,419,060*
9,377,079
Diluted Average Shares
9,381,344
9,381,344
7,783,182*
9,377,079
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive (loss) income
-$6,458K
(-255.54%↓ Y/Y)
Net (loss) income
-$6,457K
(-254.96%↓ Y/Y)
Unrealized loss on
short-term investments
-$1K
(93.33%↑ Y/Y)
Interest income
$172K
(-54.38%↓ Y/Y)
Loss from operations
-$6,629K
(25.26%↑ Y/Y)
Total operating
expenses
$6,629K
(-25.26%↓ Y/Y)
Research and development
$4,002K
(-31.07%↓ Y/Y)
General and
administrative
$2,627K
(-14.23%↓ Y/Y)
Buy us a coffee
Tvardi Therapeutics, Inc. (TVRD)
Tvardi Therapeutics, Inc. (TVRD)